Published on Monday March 06, 2023

Smooth Drug Development February 2023 News Release

We are working on the following new projects:

  • We were awarded with projects for development of medical documentation and data management.
  • Smooth received a project for a BE trial of Lopinavir.
  • We are signing two contracts for user testing of a package insert services.

We are happy to reach the following milestones in our projects:

  • All sites were closed in the Dapagliflozin, Hymecromone, Apixaban and Rosuvastatin trials.
  • All sited were closed the Nimesulide trial with dorsopathy.
  • The projects with Sofosbuvir, Lopinavir and Ibuprofen was started.
  • The approval was received from Kazakhstan authorities in the observational program of multivitamins in pregnant and childbearing women.